177 related articles for article (PubMed ID: 21309045)
1. Country of birth, socioeconomic factors, and risk factor control in patients with type 2 diabetes: a Swedish study from 25 primary health-care centres.
Sundquist K; Chaikiat A; León VR; Johansson SE; Sundquist J
Diabetes Metab Res Rev; 2011 Mar; 27(3):244-54. PubMed ID: 21309045
[TBL] [Abstract][Full Text] [Related]
2. Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register.
Eliasson B; Eeg-Olofsson K; Cederholm J; Nilsson PM; Gudbjörnsdóttir S;
Diabetes Metab; 2007 Sep; 33(4):269-76. PubMed ID: 17499541
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
Yurgin N; Secnik K; Lage MJ
Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
[TBL] [Abstract][Full Text] [Related]
4. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia.
Khan HA; Sobki SH; Khan SA
Clin Exp Med; 2007 Mar; 7(1):24-9. PubMed ID: 17380302
[TBL] [Abstract][Full Text] [Related]
5. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.
Lind M; Olsson M; Rosengren A; Svensson AM; Bounias I; Gudbjörnsdottir S
Diabetologia; 2012 Nov; 55(11):2946-53. PubMed ID: 22895807
[TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
[TBL] [Abstract][Full Text] [Related]
7. The influence of structure, process, and policy on HbA(1c) levels in treatment of children and adolescents with type 1 diabetes.
Hanberger L; Samuelsson U; Berterö C; Ludvigsson J
Diabetes Res Clin Pract; 2012 Jun; 96(3):331-8. PubMed ID: 22326692
[TBL] [Abstract][Full Text] [Related]
8. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management.
Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T
Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598
[TBL] [Abstract][Full Text] [Related]
9. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.
Lind M; Bounias I; Olsson M; Gudbjörnsdottir S; Svensson AM; Rosengren A
Lancet; 2011 Jul; 378(9786):140-6. PubMed ID: 21705065
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
[TBL] [Abstract][Full Text] [Related]
11. Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study.
Huppertz E; Pieper L; Klotsche J; Stridde E; Pittrow D; Böhler S; Lehnert H
Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):6-14. PubMed ID: 18465681
[TBL] [Abstract][Full Text] [Related]
12. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.
Soulimane S; Simon D; Shaw JE; Zimmet PZ; Vol S; Vistisen D; Magliano DJ; Borch-Johnsen K; Balkau B
Diabet Med; 2011 Nov; 28(11):1311-8. PubMed ID: 21824186
[TBL] [Abstract][Full Text] [Related]
13. HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2.
Sugawara A; Kawai K; Motohashi S; Saito K; Kodama S; Yachi Y; Hirasawa R; Shimano H; Yamazaki K; Sone H
Diabetologia; 2012 Aug; 55(8):2128-31. PubMed ID: 22580991
[TBL] [Abstract][Full Text] [Related]
14. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
[TBL] [Abstract][Full Text] [Related]
15. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.
Ahmad Khan H
Acta Diabetol; 2007 Dec; 44(4):193-200. PubMed ID: 17786383
[TBL] [Abstract][Full Text] [Related]
17. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.
Currie CJ; Peters JR; Tynan A; Evans M; Heine RJ; Bracco OL; Zagar T; Poole CD
Lancet; 2010 Feb; 375(9713):481-9. PubMed ID: 20110121
[TBL] [Abstract][Full Text] [Related]
18. Earlier triple therapy with pioglitazone in patients with type 2 diabetes.
Charpentier G; Halimi S;
Diabetes Obes Metab; 2009 Sep; 11(9):844-54. PubMed ID: 19614944
[TBL] [Abstract][Full Text] [Related]
19. Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study.
Wang W; Lee ET; Howard BV; Fabsitz RR; Devereux RB; Welty TK
Diabetes Care; 2011 Feb; 34(2):363-8. PubMed ID: 21270194
[TBL] [Abstract][Full Text] [Related]
20. The association between diabetes metabolic control and drug adherence in an indigent population.
Schectman JM; Nadkarni MM; Voss JD
Diabetes Care; 2002 Jun; 25(6):1015-21. PubMed ID: 12032108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
